Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer.

Bidgood, Charles L; Philp, Lisa K; Rockstroh, Anja; Lehman, Melanie; Nelson, Colleen C; Sadowski, Martin C.; Gunter, Jennifer H (2024). Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell death & disease, 15(7), p. 513. Springer Nature 10.1038/s41419-024-06893-2

[img]
Preview
Text
s41419-024-06893-2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (6MB) | Preview

Metabolic reprogramming and energetic rewiring are hallmarks of cancer that fuel disease progression and facilitate therapy evasion. The remodelling of oxidative phosphorylation and enhanced lipogenesis have previously been characterised as key metabolic features of prostate cancer (PCa). Recently, succinate-dependent mitochondrial reprogramming was identified in high-grade prostate tumours, as well as upregulation of the enzymes associated with branched-chain amino acid (BCAA) catabolism. In this study, we hypothesised that the degradation of the BCAAs, particularly valine, may play a critical role in anapleurotic refuelling of the mitochondrial succinate pool, as well as the maintenance of intracellular lipid metabolism. Through the suppression of BCAA availability, we report significantly reduced lipid content, strongly indicating that BCAAs are important lipogenic fuels in PCa. This work also uncovered a novel compensatory mechanism, whereby fatty acid uptake is increased in response to extracellular valine deprivation. Inhibition of valine degradation via suppression of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) resulted in a selective reduction of malignant prostate cell proliferation, decreased intracellular succinate and impaired cellular respiration. In combination with a comprehensive multi-omic investigation that incorporates next-generation sequencing, metabolomics, and high-content quantitative single-cell imaging, our work highlights a novel therapeutic target for selective inhibition of metabolic reprogramming in PCa.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Sadowski, Martin

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

2041-4889

Publisher:

Springer Nature

Language:

English

Submitter:

Pubmed Import

Date Deposited:

19 Jul 2024 14:38

Last Modified:

19 Jul 2024 14:46

Publisher DOI:

10.1038/s41419-024-06893-2

PubMed ID:

39025852

BORIS DOI:

10.48350/199098

URI:

https://boris.unibe.ch/id/eprint/199098

Actions (login required)

Edit item Edit item
Provide Feedback